311 related articles for article (PubMed ID: 21556343)
1. Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design.
Hao J; Fang X; Zhou Y; Wang J; Guo F; Li F; Peng X
Int J Nanomedicine; 2011; 6():683-92. PubMed ID: 21556343
[TBL] [Abstract][Full Text] [Related]
2. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity.
Baig MS; Ahad A; Aslam M; Imam SS; Aqil M; Ali A
Int J Biol Macromol; 2016 Apr; 85():258-70. PubMed ID: 26740466
[TBL] [Abstract][Full Text] [Related]
3. Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin.
Abul Kalam M; Sultana Y; Ali A; Aqil M; Mishra AK; Aljuffali IA; Alshamsan A
J Biomed Mater Res A; 2013 Jun; 101(6):1813-27. PubMed ID: 23255511
[TBL] [Abstract][Full Text] [Related]
4. Optimization of methazolamide-loaded solid lipid nanoparticles for ophthalmic delivery using Box-Behnken design.
Wang F; Chen L; Jiang S; He J; Zhang X; Peng J; Xu Q; Li R
J Liposome Res; 2014 Sep; 24(3):171-81. PubMed ID: 24611687
[TBL] [Abstract][Full Text] [Related]
5. Novel Solid Lipid Nanocarrier of Glibenclamide: A Factorial Design Approach with Response Surface Methodology.
Pandey S; Patel P; Gupta A
Curr Pharm Des; 2018; 24(16):1811-1820. PubMed ID: 29788881
[TBL] [Abstract][Full Text] [Related]
6. Design and optimization of curcumin loaded nano lipid carrier system using Box-Behnken design.
Agrawal M; Saraf S; Pradhan M; Patel RJ; Singhvi G; Ajazuddin ; Alexander A
Biomed Pharmacother; 2021 Sep; 141():111919. PubMed ID: 34328108
[TBL] [Abstract][Full Text] [Related]
7. Optimization by design of etoposide loaded solid lipid nanoparticles for ocular delivery: Characterization, pharmacokinetic and deposition study.
Ahmad I; Pandit J; Sultana Y; Mishra AK; Hazari PP; Aqil M
Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():959-970. PubMed ID: 30948132
[TBL] [Abstract][Full Text] [Related]
8. Preparation, optimization and characteristic of huperzine a loaded nanostructured lipid carriers.
Yang CR; Zhao XL; Hu HY; Li KX; Sun X; Li L; Chen DW
Chem Pharm Bull (Tokyo); 2010 May; 58(5):656-61. PubMed ID: 20460792
[TBL] [Abstract][Full Text] [Related]
9. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
[TBL] [Abstract][Full Text] [Related]
10. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
Dudhipala N; Janga KY
Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
[TBL] [Abstract][Full Text] [Related]
11. Ciprofloxacin hydrochloride-loaded glyceryl monostearate nanoparticle: factorial design of Lutrol F68 and Phospholipon 90G.
Shah M; Agrawal Y
J Microencapsul; 2012; 29(4):331-43. PubMed ID: 22251240
[TBL] [Abstract][Full Text] [Related]
12. Effects of Formulation Variables on the Particle Size and Drug Encapsulation of Imatinib-Loaded Solid Lipid Nanoparticles.
Gupta B; Poudel BK; Pathak S; Tak JW; Lee HH; Jeong JH; Choi HG; Yong CS; Kim JO
AAPS PharmSciTech; 2016 Jun; 17(3):652-62. PubMed ID: 26304931
[TBL] [Abstract][Full Text] [Related]
13. Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers.
Thatipamula R; Palem C; Gannu R; Mudragada S; Yamsani M
Daru; 2011; 19(1):23-32. PubMed ID: 22615636
[TBL] [Abstract][Full Text] [Related]
14. Design Optimization and Evaluation of Solid Lipid Nanoparticles of Azelnidipine for the treatment of Hypertension.
Kanugo A; Dugad T
Recent Pat Nanotechnol; 2022 Oct; ():. PubMed ID: 36278461
[TBL] [Abstract][Full Text] [Related]
15. Preparation, Statistical Optimization and Characterization of Propolis-Loaded Solid Lipid Nanoparticles Using Box-Behnken Design.
Taherzadeh S; Naeimifar A; Mehrabani Yeganeh E; Esmaili Z; Mahjoub R; Akbari Javar H
Adv Pharm Bull; 2021 Feb; 11(2):301-310. PubMed ID: 33880352
[No Abstract] [Full Text] [Related]
16. Preparation, optimization, characterization and in vivo pharmacokinetic study of asiatic acid tromethamine salt-loaded solid lipid nanoparticles.
Lingling G; Yuan Z; Weigen L
Drug Dev Ind Pharm; 2016 Aug; 42(8):1325-33. PubMed ID: 26821124
[TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization, pharmacokinetics and tissue distribution of solid lipid nanoparticles loaded with tetrandrine.
Li S; Ji Z; Zou M; Nie X; Shi Y; Cheng G
AAPS PharmSciTech; 2011 Sep; 12(3):1011-8. PubMed ID: 21811889
[TBL] [Abstract][Full Text] [Related]
18. Optimization of nanostructured lipid carriers for topical delivery of nimesulide using Box-Behnken design approach.
Moghddam SM; Ahad A; Aqil M; Imam SS; Sultana Y
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):617-624. PubMed ID: 27050533
[TBL] [Abstract][Full Text] [Related]
19. Novel cationic lipid nanoparticles as an ophthalmic delivery system for multicomponent drugs: development, characterization, in vitro permeation, in vivo pharmacokinetic, and molecular dynamics studies.
Wang J; Zhao F; Liu R; Chen J; Zhang Q; Lao R; Wang Z; Jin X; Liu C
Int J Nanomedicine; 2017; 12():8115-8127. PubMed ID: 29158673
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporine a loaded solid lipid nanoparticles: optimization of formulation, process variable and characterization.
Varia JK; Dodiya SS; Sawant KK
Curr Drug Deliv; 2008 Jan; 5(1):64-9. PubMed ID: 18220553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
